Protamine shows promise for new types of contact lens disinfectant
Nov. 7, 2016 – Protamine — a natural protein with a proven safety record — may be useful in developing new types of disinfectant solutions for contact lenses, according to a study published in the November issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.
In laboratory tests, protamine solutions perform at least as well as current disinfectant solutions in killing microbes that can cause contact lens-related infections, according to the report by Mahesh K. Bandara, PhD, and colleagues of University of New South Wales, Sydney. But more research will be needed to assess the safety and effectiveness of protamine-containing solutions before they are adopted for broader use in contact lens care.
Protamine Kills Microbes — Including Causes of Contact Lens Infections
The researchers performed a series of experiments to evaluate the antimicrobial effects of protamine solutions, with and without additives commonly used in contact lens disinfectant products. Originally derived from salmon, protamine is already used for other medical purposes — especially as an antidote to the anti-blood clotting drug heparin.
Following industry standards, the study tested protamine solutions for antimicrobial activity against a standard laboratory panel of microbes, as well as against organisms isolated from patient samples. Potential toxic effects on cultured cells were evaluated as well.
The results showed significant antimicrobial effects of protamine solutions. The effects were "dose-dependent" — the higher the protamine concentration, the greater the microbe-killing effectiveness. Protamine killed a wide range of bacteria, yeasts, and fungi, including common causes of contact lens-related infections.
Against most organisms, protamine was even more effective in solutions containing common additives. In standard tests, the antimicrobial effects of protamine were comparable to those of commercially available contact lens disinfectant solutions. All solutions tested had minimal toxicity indicating that they also had a good safety profile.
Infections of the cornea — the clear, outermost layer of the eye–are a potentially serious complication of contact lens wear. Many different risk factors have been identified, including poor contact lens cleaning and disinfection routines.
Millions of people worldwide use multipurpose disinfecting solutions to disinfect, clean, rinse, and store their contact lenses. However, these solutions may not always be effective against bacteria and other organisms. With its broad spectrum of antimicrobial activity and long history of medical use, protamine could be a useful alternative for use in contact lens care products.
"This study highlights the potential for protamine to be used for the development of effective multipurpose disinfection solutions," Dr. Bandara and colleagues conclude. At least in laboratory studies, protamine solutions have a "progressive dose-dependent killing effect" on bacteria and other organisms that can cause corneal infections.
"Protamine represents a new strategy and a very different type of compound to help defend against ocular infections related to contact lens use," comments Michael Twa, OD, PhD, FAAO, Editor-in-Chief of Optometry and Vision Science. Further research will be needed to evaluate protamine's stability, compatibility with contact lens materials, and safety for use with contact lens care products and the eye.
Click here to read "Evaluation of Protamine as a Disinfectant for Contact Lenses."
Article: "Evaluation of Protamine as a Disinfectant for Contact Lenses" (doi: 10.1097/OPX.0000000000000964)
About Optometry and Vision Science
Optometry and Vision Science, official journal of the American Academy of Optometry, is the most authoritative source for current developments in optometry, physiological optics, and vision science. This frequently cited monthly scientific journal has served primary eye care practitioners for more than 90 years, promoting vital interdisciplinary exchange among optometrists and vision scientists worldwide. Michael Twa, OD, PhD, FAAO, of University of Alabama-Birmingham School of Optometry is Editor-in-Chief of Optometry and Vision Science. The editorial office may be contacted at [email protected]
About the American Academy of Optometry
Founded in 1922, the American Academy of Optometry is committed to promoting the art and science of vision care through lifelong learning. All members of the Academy are dedicated to the highest standards of optometric practice through clinical care, education or research.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.